Led by passionate experts
Science Has No Limits When It Comes to Helping People
We offer IP for different therapeutic areas with a focus on cancer therapeutics.
Pending Patents
The Research and Development team holds several pending patents on novel cannabinoids and has promising oncology studies heading into in vitro animal studies.
Years Of Chemical Experience
A Leader in Cannabis-Based Research
With a focus on cancer therapeutics.
about blackstone therapeutics
Changing the World, One Compound at a Time
At Blackstone Therapeutics our goal is to take what we have learned in the hemp and cannabinoid industries and apply it to helping those with different types of cancer around the world. We focus on developing novel therapeutics and bringing them from conception to preclinical trials, IND, and Phase 1 clinical trials.
Cannabinoids and Oncology Studies
We are a smaller pharmaceutical company dedicated to designing cancer therapeutics through the study of cannabinoids.
API Manufacturing
Expertise. Efficiency. Concentration.
Quality APIs directly correlate to the efficacy of desired results and the safety of medication. For that reason, we perform each process in accordance with Good Manufacturing Practices (GMP) requirements to meet the regulations of the FDA.
Our Collaborations
Working Together Today for a Better Tomorrow
Our research team is involved in a number of different collaborations with a focus on delivering cancer therapeutics through the study of cannabinoids.
Non-GLP synthesis of lead compounds
MTT Assays, Metabolite study and synthesis, DOE, Publications
Learn More About Our Collaborations
Latest Research
Publications and Patents
Leading Research Into Cannabinoids
Blackstone Therapeutics has on-going research projects with different lead compounds and therapeutic targets.
careers
Join Our Passionate Team
Interested in a career? Send us your information and a team member will reach out to you.
